During his time at Labcorp, David P. King had significant stock holdings which reportedly rose from around $57 million in late 2019 to approximately $100 million by late 2021. This increase showcased the market's confidence in Labcorp's direction under his...
During his time at Labcorp, David P. King had significant stock holdings which reportedly rose from around $57 million in late 2019 to approximately $100 million by late 2021. This increase showcased the market's confidence in Labcorp's direction under his leadership. Kings' holdings fluctuated over the years, reflecting both the ups and downs of the healthcare market. By 2024, fluctuations indicate his stock value remained solid, tracking between $69 million to $77 million, signaling continuous company performance despite market volatility. His wealth was heavily tied to Labcorp's stock, illustrating a strong connection between his interests and those of the shareholders.